http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20768946

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't|Review
endingPage 345
issn 1875-8908
1387-2877
issueIdentifier 2
pageRange 339-345
publicationName Journal of Alzheimer's disease : JAD
startingPage 339
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_916de93fe8f49855f42e16db43537393
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_9c78f7b66eaa37bdc38121784d066b85
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_042e263a9b02aa9f05b0d7f0f2c35a30
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_fc06904303cf256b03058d5734e3191a
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_78f26826bf28b6136e40afd0f938996a
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_e20a1bd8f397ff5f7471ac68c4b8a1e3
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_8e5aae533add4614100f787689db75ab
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_f85bb66d41f1361b9dd881079120a3cc
bibliographicCitation Iqbal K, Chohan MO, Grundke-Iqbal I. Stratification of patients is the way to go to develop neuroprotective/disease-modifying drugs for Alzheimer's disease. J Alzheimers Dis. 2008 Oct;15(2):339–45. PMID: 18953118; PMCID: PMC2676925.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_878fc0bd4524d0fd6cdcdc0e995291f4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8415d85f739761e0073a10482169e5d3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_67984e0017a2df0e98c4f0c2a4a6bdde
date 2008-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/18953118
https://doi.org/10.3233/jad-2008-15215
https://pubmed.ncbi.nlm.nih.gov/PMC2676925
isPartOf https://portal.issn.org/resource/ISSN/1875-8908
https://portal.issn.org/resource/ISSN/1387-2877
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21942
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Stratification of Patients is the Way to Go to Develop Neuroprotective/Disease-Modifying Drugs for Alzheimer's Disease
discusses http://id.nlm.nih.gov/mesh/M0028008
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D000544Q000188
http://id.nlm.nih.gov/mesh/D018696Q000627
http://id.nlm.nih.gov/mesh/D018579
hasSubjectTerm http://id.nlm.nih.gov/mesh/D002986
http://id.nlm.nih.gov/mesh/D000544Q000145
http://id.nlm.nih.gov/mesh/D012107
http://id.nlm.nih.gov/mesh/D000544Q000235
http://id.nlm.nih.gov/mesh/D000544Q000209
http://id.nlm.nih.gov/mesh/D006801
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6852
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10707
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7404
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10395

Total number of triples: 45.